Cittadine Andrew bought MNPR
June 30, 2025 · Form 4 insider transaction
Cittadine Andrew bought 6,863 shares of Monopar Therapeutics Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,863
Price
N/A
Total value
N/A
InsiderCittadine Andrew
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 30, 2025
Filing dateJuly 2, 2025
Shares owned after48,848
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares acquired on vesting and settlement of restricted stock units.